MARSHALL WACE, LLP - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 218 filers reported holding IMMUNOGEN INC in Q1 2019. The put-call ratio across all filers is 0.63 and the average weighting 0.0%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q1 2023$439,123
-61.2%
114,355
-49.9%
0.00%
-66.7%
Q4 2022$1,132,938
+0.3%
228,415
-3.3%
0.00%
+50.0%
Q3 2022$1,129,000
-73.4%
236,200
-54.8%
0.00%
-89.5%
Q1 2021$4,237,000
+609.7%
523,087
+199.0%
0.02%
+216.7%
Q1 2020$597,000
+2.6%
174,919
+53.5%
0.01%
+50.0%
Q4 2019$582,000
+85.4%
113,932
-21.2%
0.00%
+33.3%
Q2 2019$314,000
-75.0%
144,493
-44.8%
0.00%
-76.9%
Q4 2018$1,256,000261,6080.01%
Other shareholders
IMMUNOGEN INC shareholders Q1 2019
NameSharesValueWeighting ↓
Redmile Group, LLC 10,906,962$69,914,0003.04%
Fernwood Investment Management, LLC 224,500$1,439,0000.77%
Telemetry Investments, L.L.C. 272,000$1,744,0000.66%
Schonfeld Strategic Advisors LLC 865,356$5,547,0000.45%
Virtus ETF Advisers LLC 53,977$346,0000.43%
Endurant Capital Management LP 210,800$1,351,0000.41%
SPHERA FUNDS MANAGEMENT LTD. 500,000$3,205,0000.38%
TWIN FOCUS CAPITAL PARTNERS, LLC 113,216$726,0000.37%
Orbimed Advisors 2,834,126$18,167,0000.23%
PINNACLE ASSOCIATES LTD 1,322,231$8,476,0000.16%
View complete list of IMMUNOGEN INC shareholders